In
this study, we fabricated composites of conducting carbon black
(CB), room-temperature ferromagnetic Sr
3
YCo
4
O
10+δ
(SYCO) and polyvinylidenefluoride (PVDF) by
the solution mixing and coagulation method for the first time. During
the nucleation process of PVDF, the presence of SYCO and CB individually
facilitates the crystallization of polar β and semipolar γ
phases along with the nonpolar α phase in PVDF. The dc electrical
conductivity of PVDF raised from 1.54 × 10
–8
to 9.97 S/m with the addition of 30 wt % of CB, and it is nearly
constant with respect to the SYCO content. The PVDF/CB/SYCO composites
(PCS) possess high permittivity and its variation is in accordance
with the content of polar phases in PVDF. Moreover, the complex permittivity
and permeability spectra from 10 MHz to 1 GHz indicate that the dielectric
loss dictates over magnetic loss in these composites. The electromagnetic
interference shielding effectiveness (EMI SE) of PCS composites is
higher than that of PVDF/CB and PVDF/SYCO composites in the 8.2–18
GHz region. Addition of SYCO in the PVDF/CB matrix enhances shielding
by dominated absorption with minimal reflection. The analysis of the
shielding mechanism suggests that in addition to conducting and magnetic
losses due to CB and SYCO, respectively, the synergy among CB, SYCO,
and PVDF promotes shielding by matching the input impedance to that
of free space, enhancing multiple internal reflections from SYCO and
subsequent absorption by CB, eddy current losses, dielectric damping
losses, interfacial polarization losses, and so forth. These different
mechanisms result in an enhanced EMI SE of 50.2 dB for the PCS-40
composite for a thickness of 2.5 mm.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.